Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events

BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
Antonio AbbateGiuseppe Biondi-Zoccai

Abstract

The inflammatory hypothesis of atherosclerosis postulates that inflammation within the plaque promotes plaque progression and complications. Interleukin-1 (IL-1) is a key pro-inflammatory cytokine responsible for the amplification of the inflammatory response following injury. Animal studies show that IL-1 blockade is effective in limiting atherosclerosis and atherothrombosis and improving outcomes in acute myocardial infarction and ischemic stroke. Preliminary data in patients with acute myocardial infarction, ischemic stroke, and heart failure are promising. A large secondary prevention trial with canakinumab in patients with prior acute myocardial infarction is currently ongoing. Many unanswered questions remain regarding the optimal use of IL-1 blockade and the preferred agent.

References

Aug 18, 1994·The New England Journal of Medicine·G LiuzzoA Maseri
Sep 1, 1996·Circulation·L M BiasucciA Maseri
Apr 3, 1997·The New England Journal of Medicine·P M RidkerC H Hennekens
Jun 1, 1997·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·R P Stroemer, N J Rothwell
Feb 12, 1998·The New England Journal of Medicine·A D Luster
Jan 14, 1999·The New England Journal of Medicine·R Ross
Nov 14, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·R DewberryS Francis
Jun 30, 2001·The New England Journal of Medicine·P M RidkerUNKNOWN Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators
Aug 31, 2001·JAMA : the Journal of the American Medical Association·D MukherjeeE J Topol
Feb 12, 2002·The American Journal of Cardiology·Giuseppe PattiAldo Dobrina
Mar 6, 2002·Circulation·Peter LibbyAttilio Maseri
Dec 12, 2002·Journal of the American College of Cardiology·Francesco VersaciUNKNOWN Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation Study
Apr 26, 2003·The American Journal of Cardiology·Gregory R GiuglianoRichard E Kuntz
Apr 30, 2003·Circulation·Attilio Maseri, Valentin Fuster
Apr 3, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Kikuo IsodaFumitaka Ohsuzu
Jun 17, 2004·Seminars in Vascular Medicine·Antonio AbbateLuigi M Biasucci
Jun 24, 2004·Circulation·Antonio AbbateFilippo Crea
Jul 14, 2004·Circulation·P PignatelliF Violi
Jan 7, 2005·The New England Journal of Medicine·Paul M RidkerUNKNOWN Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Inv
Jun 1, 2005·The American Journal of Cardiology·Douglas L Mann
Sep 20, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·H C A EmsleyUNKNOWN Acute Stroke Investigators
Jan 7, 2006·Annals of the Rheumatic Diseases·R M FleischmannB Appleton
Mar 27, 2007·European Heart Journal·Antonio AbbateGeorge W Vetrovec

❮ Previous
Next ❯

Citations

May 8, 2013·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Benjamin W Van TassellAntonio Abbate
Nov 28, 2013·Seminars in Immunology·Charles A Dinarello, Jos W M van der Meer
Nov 20, 2012·Current Opinion in Lipidology·Fleur M van der ValkErik S G Stroes
Jul 30, 2019·Oxidative Medicine and Cellular Longevity·Patricia MarchioMaria D Mauricio
Jun 12, 2019·Inflammation and Regeneration·Naoe KanekoJunya Masumoto
Dec 31, 2019·Journal of Immunology Research·Hailin XuZhigang Chen
Jun 14, 2017·International Journal of Molecular Sciences·Megan YuYu-Min Kuo
May 14, 2019·European Heart Journal·Tinna ChristersdottirMartin Halle
Sep 17, 2020·Human & Experimental Toxicology·S ZareG Karimi
Feb 18, 2014·American Journal of Physiology. Heart and Circulatory Physiology·Stefano ToldoAntonio Abbate
Jul 26, 2015·Rheumatology·Giulio Cavalli, Charles A Dinarello
Oct 1, 2015·Expert Opinion on Therapeutic Targets·Gerardus P J van HoutImo E Hoefer
Jan 26, 2013·Experimental Physiology·Antonio Abbate
Oct 23, 2013·Circulation·Benjamin W Van TassellAntonio Abbate
Jan 23, 2020·Cells·Aldo BonaventuraFabrizio Montecucco
Jan 15, 2020·Current Atherosclerosis Reports·Giuseppe Biondi-ZoccaiFrancesco Versaci
Mar 19, 2014·International Heart Journal·Masafumi Takahashi
Dec 29, 2020·Frontiers in Immunology·Wuqian Mai, Yuhua Liao
Jan 1, 2018·Current Otorhinolaryngology Reports·Charles A Dinarello
Jun 19, 2013·The American Journal of Pathology·Sruthi SundaramSandra E Reznik
Oct 28, 2017·Journal of the American College of Cardiology·Peter Libby

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.